ArticleEJHaem2026
Sézary Syndrome: Survival Trends, Racial Disparities, and Limited Prognostic Value of Routine Registry Variables.
Article in EJHaem, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Sézary syndrome (SS) is a rare leukemic cutaneous T-cell lymphoma with limited contemporary population-level outcome data. Methods: Using SEER-22, we identified 403 adults with first primary SS diagnosed from 2000-2021 and evaluated survival, disparities, and prognostic modeling. Results: Median overall survival (OS) was 48 months; 5-year OS was 42.7%. Survival improved from 39.5 months in 2000-2010 to 56.0 months in 2011-2021. Black patients were diagnosed younger and had worse adjusted mortality than White patients. Machine-learning and conventional models showed limited discrimination. Conclusion: SS remains highly lethal, with persistent racial disparities and limited prognostic value of routine registry variables. Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.